Previous Page  2 / 10 Next Page
Information
Show Menu
Previous Page 2 / 10 Next Page
Page Background

Page 16

Volume 2

Journal of Clinical Diagnosis and Treatment

Annual Nephrology & Chronic Diseases 2019

May 20-21, 2019

Nephrology

Chronic Diseases

May 20-21, 2019 London, UK

19

th

Annual Conference on

3

rd

International Conference on

&

Mingxia Yuan et al., J Clinical Diagnosis and Treatment, Volume 2

More sustained combined target control leading to less cardiovascular events and all-

cause mortality in patients with type 2 diabetes mellitus

Mingxia Yuan

1

, Gang Wan

2

, Guangran Yang

1

, Xuelian Zhang

1

, Liangxiang Zhu

1

, Jianping Feng

1

, Rongrong Xie

1

, Ning Zhuang

3

,

Hanjing Fu

1

and

Shenyuan Yuan

1

1

Beijing Tongren Hospital, Capital Medical University, China

2

Beijing Ditan Hospital, Capital Medical University, China

3

Jinsong Community Health Service Center, China

Chronic complications are the major causes of disabilities

and death for diabetic patients. It is well-established that

intensive glycemia, blood pressure and lipid management in

people with diabetes reduces the risk of microvascular and

macrovascular complications, mainly on the basis of evidence

from large randomized clinical trials. Yet, translation of these

interventions to day-to-day-life settings remains a major

challenge. Meanwhile, the GPs from the local healthcare

community remain a relatively untapped pool of resources in

China. An urgent problem is whether the quality of diabetes

care will be compromised as diabetes care shifts increasingly

from specialist to primary level. We thus launched the 10-year Beijing Community Diabetes Study (BCDS), to

develop a community-hospital integrated management system, with the purpose of translating optimal care to

the real-world clinical practice by increasingly involve community GPs in diabetes management.

Objective:

To assess the quality and effort of the community-hospital integrated diabetes care model, focusing

on the effect of the 10-year combined target control on all-cause mortality and cardiovascular events for the

patients with type 2 diabetes mellitus (T2DM)

Methods:

The patients aged 20 to 80 years with T2DM from 15 community health centers among five urban

districts were recruited at the baseline (betweenAugust 2008 and July 2009), andwere followed up to September

2018. Management adjustment strategies on guidelines have been applied by a group of collaborative team

members consisting of 15 specialists from tertiary hospital and 120 community GPs. A systemic scheduled

training course, including hand-by-hand tutor at the outpatient clinic, were applied to the GPs. The follow-

up visit for the patients was completed on schedule. All the metabolic variables were detected. HbA1c was

measured at a central laboratory by high-pressure liquid chromatographic assay. To ensure the integrity and

also quality of data collection, a supervision team which includes four trained specialists has been checking